Explore how E-selectin-targeted polymer-doxorubicin therapy induces regression in colorectal liver metastases.

To achieve more energy-dense batteries that aren’t unsustainably expensive, faster battery development is needed, as well as ...

With a market cap of $18.3 billion, Secaucus, New Jersey-based Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing and services globally. It offers a wide range of ...

The linear model is a modelling workhorse for data analyses commonly referred to in the social and behavioural sciences as regression analysis and is an essential building ... in light of the ...

In this article, we are going to take a look at where Quest Diagnostics Incorporated (NYSE:DGX) stands against other most undervalued pot stocks to buy according to analysts. A decade ago ...

Bharath Advanced Therapeutics (BAT) and the Federation of Asian Biotech Associations (FABA) are proud to jointly present ...

After hours: November 29 at 4:55 PM EST Loading Chart for DGX ...

Research found that younger age at type 2 diabetes diagnosis is associated with higher risks of cardiovascular and all-cause ...

The firm is engaging with regulators about its recently validated Ataraxis Breast test, which it hopes to make available for clinical use next year.

Suraksha Diagnostic IPO: The Rs 846.25 crore IPO is open for bidding from Friday, November 29, 2024, onward. In the first half of Day 1, the IPO received tepid demand from across investor categories.